Liangliang Jia

1.1k total citations
31 papers, 671 citations indexed

About

Liangliang Jia is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Liangliang Jia has authored 31 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Biomedical Engineering. Recurrent topics in Liangliang Jia's work include Nanoplatforms for cancer theranostics (8 papers), Aortic aneurysm repair treatments (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Liangliang Jia is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Aortic aneurysm repair treatments (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Liangliang Jia collaborates with scholars based in China, Japan and United States. Liangliang Jia's co-authors include Zhejun Cai, Yidong Wang, Sheng‐an Su, Meixiang Xiang, Zurong Fu, Yaping Wang, Jianan Wang, Yao Xie, Jian Shen and Zhenjie Liu and has published in prestigious journals such as ACS Nano, Biomaterials and Advanced Functional Materials.

In The Last Decade

Liangliang Jia

27 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangliang Jia China 14 342 130 119 90 89 31 671
Qi Long China 17 447 1.3× 127 1.0× 116 1.0× 46 0.5× 77 0.9× 44 787
Xinping Luo China 15 449 1.3× 107 0.8× 94 0.8× 48 0.5× 155 1.7× 26 834
Sayantan Jana Canada 14 186 0.5× 126 1.0× 132 1.1× 166 1.8× 80 0.9× 33 755
Marion Muhly-Reinholz Germany 14 369 1.1× 178 1.4× 105 0.9× 102 1.1× 102 1.1× 15 847
Najat Hajji Netherlands 14 395 1.2× 81 0.6× 173 1.5× 55 0.6× 199 2.2× 22 734
Zhongping Su China 13 388 1.1× 55 0.4× 136 1.1× 58 0.6× 115 1.3× 20 736
Kyu-Sil Choi South Korea 11 383 1.1× 76 0.6× 91 0.8× 51 0.6× 106 1.2× 13 786
Michal Entin‐Meer Israel 17 449 1.3× 136 1.0× 123 1.0× 47 0.5× 82 0.9× 41 789
Gwon‐Soo Jung South Korea 15 229 0.7× 50 0.4× 71 0.6× 58 0.6× 69 0.8× 27 591

Countries citing papers authored by Liangliang Jia

Since Specialization
Citations

This map shows the geographic impact of Liangliang Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangliang Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangliang Jia more than expected).

Fields of papers citing papers by Liangliang Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangliang Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangliang Jia. The network helps show where Liangliang Jia may publish in the future.

Co-authorship network of co-authors of Liangliang Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Liangliang Jia. A scholar is included among the top collaborators of Liangliang Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangliang Jia. Liangliang Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Di, Xinyu He, Liangliang Jia, et al.. (2025). Carrier-Free Nanoprodrug Mediating Laser-Activable Chemotherapeutic Immunomodulation against Cancer. ACS Nano. 19(35). 31582–31597.
3.
Ren, Xuechun, Di Gao, Xinyang Liu, et al.. (2025). UCST Polymeric H2S‐Donor Fabricated Nanomedicine Managing Atherosclerosis by Gas‐Photothermal Therapy Involving a “Turning Waste into Treasure” Strategy. Advanced Functional Materials. 35(20). 4 indexed citations
4.
Tan, Li‐Feng, Benjamin Yong‐Qiang Tan, Yee Wei Lim, et al.. (2025). Intrinsic capacity deficits across the lifespan in a nationally representative community cohort: findings from the Queenstown study. Archives of Gerontology and Geriatrics. 140. 106031–106031.
5.
Yang, Zhe, Ying Zhou, Xinyang Liu, et al.. (2024). Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells. Biomaterials. 314. 122883–122883. 11 indexed citations
6.
Jia, Liangliang, et al.. (2024). Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters. 36(2). 109957–109957. 10 indexed citations
7.
Wang, Yidong, Zhenjie Liu, Chunna Jin, et al.. (2024). IRF5 governs macrophage adventitial infiltration to fuel abdominal aortic aneurysm formation. JCI Insight. 9(3). 6 indexed citations
8.
Lin, Qing, Liangliang Jia, Hui Li, et al.. (2023). Rehmannia alcohol extract inhibits neuropeptide secretion and alleviates osteoarthritis pain through cartilage protection. Heliyon. 9(9). e19322–e19322. 1 indexed citations
9.
Wang, Ying, Di Gao, Lin Jin, et al.. (2022). NADPH Selective Depletion Nanomedicine‐Mediated Radio‐Immunometabolism Regulation for Strengthening Anti‐PDL1 Therapy against TNBC. Advanced Science. 10(3). e2203788–e2203788. 31 indexed citations
10.
Zhao, Bin, Sa Chen, Liangliang Jia, et al.. (2022). Research Progress of Conjugated Nanomedicine for Cancer Treatment. Pharmaceutics. 14(7). 1522–1522. 11 indexed citations
11.
Li, Xihai, Hui Li, Liangliang Jia, et al.. (2021). Verification of pain-related neuromodulation mechanisms of icariin in knee osteoarthritis. Biomedicine & Pharmacotherapy. 144. 112259–112259. 19 indexed citations
12.
Wang, Yidong, Liangliang Jia, Yao Xie, et al.. (2019). Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development. Atherosclerosis. 289. 64–72. 60 indexed citations
13.
Lin, Kunzhang, Qing Liu, Xiaoping Huang, et al.. (2019). Rabies Virus Pseudotyped with CVS-N2C Glycoprotein as a Powerful Tool for Retrograde Neuronal Network Tracing. Neuroscience Bulletin. 36(3). 202–216. 26 indexed citations
14.
Wei, Jia, Daxing Tang, Jin Yang, et al.. (2019). Irf5 deficiency in myeloid cells prevents necrotizing enterocolitis by inhibiting M1 macrophage polarization. Mucosal Immunology. 12(4). 888–896. 36 indexed citations
15.
Li, Xihai, Zhenli Zhang, Wenna Liang, et al.. (2019). Data on Tougu Xiaotong capsules may inhibit p38 MAPK pathway-mediated inflammation in vitro. Data in Brief. 28. 105023–105023. 6 indexed citations
16.
Fu, Zurong, Fei Li, Liangliang Jia, et al.. (2018). Histone deacetylase 6 reduction promotes aortic valve calcification via an endoplasmic reticulum stress-mediated osteogenic pathway. Journal of Thoracic and Cardiovascular Surgery. 158(2). 408–417.e2. 29 indexed citations
18.
Chen, Jie, Jun Gu, Jian Feng, et al.. (2015). TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway. Tumor Biology. 37(3). 3851–3861. 13 indexed citations
19.
Ni, Tingting, Guoxin Mao, Qun Xue, et al.. (2015). Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis. Journal of Molecular Histology. 46(4-5). 325–335. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026